Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis

INTRODUCTION: The consistency of the treatment effect of galcanezumab throughout the dosing interval is examined in patients with episodic and chronic migraine. METHODS: This study was a post hoc analysis of clinical trial data from episodic (EVOLVE-1; EVOLVE-2; both 6-month duration) and chronic (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozo-Rosich, Patricia, Samaan, Karen H., Schwedt, Todd J., Nicholson, Robert A., Rettiganti, Mallikarjuna, Pearlman, Eric M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189981/
https://www.ncbi.nlm.nih.gov/pubmed/33950375
http://dx.doi.org/10.1007/s12325-021-01708-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189981/
https://www.ncbi.nlm.nih.gov/pubmed/33950375
http://dx.doi.org/10.1007/s12325-021-01708-8

Ejemplares similares